Significant decreases in depression severity in IN-NPY patients were observed at 5 and 24 h post-treatment, with a progressive decrease from the 5 to 24 h mark, though no significant differences from placebo were seen at 48 h [123]. This evidence concerns the gene NPY and depressive symptom measurement.